{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:33:02Z","timestamp":1780363982777,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ygyno.2020.09.042","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T16:35:37Z","timestamp":1601656537000},"page":"706-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study"],"prefix":"10.1016","volume":"159","author":[{"given":"Jorne","family":"Ubachs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone N.","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Lahaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Bruijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Schagen van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk W.R.","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.H.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Arts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vuylsteke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacco","family":"Bastings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy F.P.M.","family":"Kruitwagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrina","family":"Lambrechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.M.","family":"Olde Damink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander S.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Van Gorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabe S.","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemien J.","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2020.09.042_bb0005","first-page":"S161","article-title":"Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.042_bb0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrclinonc.2015.224","article-title":"Can advanced-stage ovarian cancer be cured?","volume":"13","author":"Narod","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.042_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2017.10.030","article-title":"No improvement in long-term survival for epithelial ovarian cancer patients: a population-based study between 1989 and 2014 in the Netherlands","volume":"88","author":"Timmermans","year":"2017","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2020.09.042_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199503093321002","article-title":"The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer cooperative Group of the European Organization for research and treatment of Cancer","volume":"332","author":"van der Burg","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ygyno.2020.09.042_bb0025","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.042_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2016.05.022","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of clinical oncology clinical practice guideline","volume":"143","author":"Wright","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.042_bb0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.042_bb0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ygyno.2018.07.004","article-title":"Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer","volume":"150","author":"Timmermans","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.09.042_bb0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.09.042_bb0050","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl. Physiol. Nutr. Metab."},{"issue":"6","key":"10.1016\/j.ygyno.2020.09.042_bb0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1139\/apnm-2013-0403","article-title":"The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer","volume":"39","author":"Prado","year":"2014","journal-title":"Appl. Physiol. Nutr. Metab."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.042_bb0060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00280-017-3395-5","article-title":"Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers","volume":"80","author":"Yoshikawa","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.042_bb0065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jcsm.12107","article-title":"Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients","volume":"7","author":"Rutten","year":"2016","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.042_bb0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejso.2016.12.016","article-title":"The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery","volume":"43","author":"Rutten","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.042_bb0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/IGC.0000000000000867","article-title":"Sarcopenia in advanced serous ovarian Cancer","volume":"27","author":"Bronger","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.042_bb0080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/IGC.0000000000001157","article-title":"Sarcopenia and skeletal muscle quality as predictors of postoperative complication and early mortality in gynecologic cancer","volume":"28","author":"Silva de Paula","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.042_bb0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.042_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.042_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the gynecological cancer intergroup (GCIG)","volume":"21","author":"Rustin","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2020.09.042_bb0100","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/17512433.2017.1347503","article-title":"A review of body composition and pharmacokinetics in oncology","volume":"10","author":"Hopkins","year":"2017","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.ygyno.2020.09.042_bb0105","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.042_bb0110","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/jcsm.12180","article-title":"Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer","volume":"8","author":"Rutten","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.042_bb0115","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jcsm.12221","article-title":"Psoas as a sentinel muscle for sarcopenia: a flawed premise","volume":"8","author":"Baracos","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.042_bb0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2016.05.027","article-title":"Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer","volume":"142","author":"Kumar","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2020.09.042_bb0125","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1245\/s10434-018-6683-3","article-title":"Skeletal muscle attenuation (sarcopenia) predicts reduced overall survival in patients with advanced epithelial ovarian Cancer undergoing primary Debulking surgery","volume":"25","author":"Ataseven","year":"2018","journal-title":"Ann. Surg. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820339524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820339524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:56:37Z","timestamp":1758772597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820339524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0090825820339524"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.042","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}